cas 162635-04-3, Temsirolimus | Articles data

Articles about 162635-04-3Total 17 be found

Article title
Article abstract
Author
Journal number and time
Download

Temsirolimus intermediate compound
The invention belongs to the field of pharmaceutical chemicals, and particularly relates to a temsirolimus intermediate compound. The preparation method of the temsirolimus intermediate compound comprises the following steps: inert gas protection, addition of a compound VI and a compound VII into an organic solvent A, addition of organic alkali, temperature control reaction, TLC detection, addition of a solvent B for dilution after the reaction is finished, drying with anhydrous sodium sulfate, and vacuum concentration, thereby obtaining a compound I. The invention provides the novel temsirolimus intermediate compound I. When the compound is used for preparing temsirolimus, generation of by-products can be effectively avoided, and the synthesized intermediate does not generate new impurities; and the reaction is faster, economic and environment-friendly, yield is higher, and the method is suitable for industrial production.
-
(2022/03/17)

Preparation method of tansemmus
The present invention belongs to the field of pharmaceutical synthesis technology, specifically relates to a method of preparation of tansimos, the present invention preparation of tansimmus method comprising: compound VIII added to the organic solvent A, slowly adding acid, temperature control reaction, TLC detection, reaction completed, adding organic solvent B dilution, adding purified water, extraction, organic layer with anhydrous magnesium sulfate drying, filtration, reduced pressure concentration of the target compound I; provides a new method of synthesizing tansemmus, the entire synthesis method is simple to operate, high reaction yield, The resulting product is of high purity; the new intermediate compound VI provided by the present invention can effectively improve the regional selectivity of the rapamycin esterification reaction due to the large steric block during the reaction, effectively avoiding the generation of 31-esterification and 31,42-diesterification by-products.
-
(2022/03/18)

Method for separating and purifying temsirolimus
The invention discloses a method for separating and purifying temsirolimus. The method comprises the following steps: (1) synthesis of a crude product; and (2) separation and purification. The specific separation and purification method has the advantages of great improvement of the purity and the yield of temsirolimus, reduction of the cost, and broad market application prospect.
-
(2019/07/04)

Method for preparing temsirolimus
The invention discloses a method for preparing temsirolimus. The method comprises the following steps: (1) preparing 2,2,5-trimethyl-5-carboxy-1,3-dioxane; (2) cooling the 2,2,5-trimethyl-5-carboxy-1,3-dioxane and dichloromethane to 0-5 DEG C under the protection of nitrogen, performing stirring for dissolving, adding DIPEA and 2,4,6-trichlorobenzoyl chloride, and carrying out a reaction to obtainan acid anhydride product; (3) adding the acid anhydride product to dichloromethane containing rapamycin and 4-(N,N-dimethylamino)pyridine, and carrying out a reaction; and (4) mixing a product obtained in step (3) with tetrahydrofuran containing p-toluenesulfonic acid, dropwise adding ethylene glycol at 0-5 DEG C, adding water after the reaction is finished, performing extraction by using ethylacetate, and washing and drying the extracted product to prepare the temsirolimus. The method has the advantages of simple preparation process, high yield, high purity and low cost, and is suitable for industrialized production.
-
(2018/04/03)

Intermediate of temsirolimus and preparation method thereof
The invention provides an intermediate of temsirolimus. The intermediate has better selectivity and higher yield when used for preparation of the temsirolimus. The intermediate provided by the invention has a structural formula which is described in the specification.
-
(2019/01/06)

Preparation method for temsirolimus
The invention provides a preparation method for temsirolimus. The preparation method comprises the following steps: step 1, dissolving 2,2,5-trimethyl-1,3-dioxane-5-carboxylic acid in a solvent underan alkaline condition, dropwise adding a solution of 2,4,6-trichlorobenzoyl chloride under stirring at a normal temperature, after a reaction is completed, carrying out cooling, adding a rapamycin double-protection compound, then dropwise adding an alkaline solution, and carrying out a reaction so as to obtain a coupled intermediate; and step 2, dissolving the coupled intermediate into a solvent,carrying out cooling, dropwise adding an inorganic acid solution, and carrying out deprotection so as to obtain the temsirolimus. The preparation method provided by the invention has the advantages ofsimple process, easy operation, high reaction yield, few by-products and applicability to industrial production.
-
(2019/01/08)

PROCESS FOR PREPARING TORISEL
A process for preparing Torisel, which is a derivative of Rapamycin, is provided. The process comprises the following steps: acetalating 2,2-dihydroxymethylpropionic acid with substituted or unsubstituted aromatic aldehyde in the presence of p-toluenesulfonic acid as catalyst to form the intermediate II; reacting the obtained intermediate with 2,4,6-trichlorobenzoyl chloride; then esterifying the obtained chloride with Rapamycin and finally deprotecting the diol to provide the product Torisel with yield over 35.6%. The aromatic aldehyde is one selected from benzaldehyde, p-methoxybenzaldehyde, p-chlorobenzaldehyde and p-trifluoromethyl benzaldehyde.
-
Paragraph 0027

(2013/12/02)

PROCESS FOR SYNTHESIS OF TORISEL
A process for synthesis of torisel comprises the following steps: firstly, the intermediate compound II is obtained by protecting 2,2-bis(hydroxymethyl) propionic acid with substituted boracic acid, then reacted with acylation reagent 2,4,6-trichlorobenzoyl chloride, and then condensed with rapamycin, last deprotected with diol to obtain torisel. The whole yield is 54.8%.
-
Paragraph 0027

(2013/12/02)

REGIOSELECTIVE ACYLATION OF RAPAMYCIN AT THE C-42 POSITION
The invention refers to the selective acylation of Rapamycin at the 42-position (I) with an acylating agent of the formula (II) wherein R4 and R5 are the same or different, individually the rest of an acetal, especially tetrahydropyran, or of a carbonate or the rest of a silyl ether or taken together are the rest of a boronate, an acetal or ketal.
-
Page/Page column 9

(2012/10/18)

AN IMPROVED PROCESS FOR THE PREPARATION OF TEMSIROLIMUS AND ITS INTERMEDIATES
Novel intermediates, process for their preparation and their use in the preparation of therapeutically effective antineoplastic agents, in particular Temsirolimus of formula (I).
-
(2011/08/21)

PROCESS FOR THE PREPARATION OF RAPAMYCIN DERIVATIVES
The invention relates to processes for the preparation of compound of CCI-779 having the Formula (I), which is useful as an antineoplastic agent. The invention further relates to certain novel intermediates useful in the preparation of compound of CCI-779 and processes for their preparation. The invention also relates to pharmaceutical compositions that include the compound of CCI-779, prepared according to the processes disclosed herein.
-
(2011/05/11)

PROCESS FOR THE PREPARATION OF TEMSIROLIMUS AND ITS INTERMEDIATES
Novel intermediates, process for their preparation and their use in the preparation of therapeutically effective antineoplastic agents, in particular Temsirolimus of formula (I).
-
(2011/08/06)

Process for preparation of temsirolimus
The present invention provides two synthetic routes for the preparation of Temsirolimus (compound 1b and analog of Temsirolimus 1a). The first route includes the synthesis of CCI-779 by directly reacting rapamycin (4b) or Prolyl-rapamycin (4a) with substituent-2,2-bis(methoxy) propionic acid anhydride(11) in the presence of an organic base, followed by deprotection to give CCI-779 or Proline CCI-779. The second route includes a process involving a reaction of rapamycin-OH-31-sily ether (4d) or Prolyl-rapamycin-OH-31-sily ether (4c) with substituent-2,2-bis(methoxy) propionic acid anhydride(11) in the presence of an organic base and followed by subsequent hydrolysis step to obtain the desired CCI-779 or Proline CCI-779. Compound 11, as described in this invention, is stable at room temperature, cost effective and ease of processing.
-
Page/Page column 13

(2010/10/19)

Scalable process for the preparation of a rapamycin 42-ester from a rapamycin 42-ester boronate
A scalable process for the preparation of a rapamycin 42-ester by reacting a rapamycin 42-ester boronate with a diol and purifying crude rapamycin 42-ester by recrystallization and treatment with a diol is provided. Also provided is a method for isolating and purifying a rapamycin 42-ester boronate from mother liquors comprising acetone and rapamycin contaminants.
-
Page/Page column 11-12

(2008/06/13)

Recovery of CCI-779 from mother liquors
The invention provides a process for recovering CCI-779 from mother liquors.
-
Page/Page column 4

(2008/06/13)

Lipase-catalyzed regioselective esterification of rapamycin: Synthesis of temsirolimus (CCI-779)
(Chemical Equation Presented) A lipase-catalyzed acylation of the immunosuppressant rapamycin with complete regioselectivity is described. The method was successfully applied to the synthesis of 42-hemiesters and temsirolimus (CCI-779), an investigational oncology drug.
Gu, Jianxin,Ruppen, Mark E.,Cai, Ping
p. 3945 - 3948
(2007/10/03)

Rapamycin hdroxyesters, process for their preparation and pharmaceutical compositions containing them
A compound of structure (I) wherein R1 and R2 are each, independently, hydrogen or -CO(CR3R4)b(CR5R6)dCR7R8R9 ; R3 and R4 are each, independently, hydrogen, alkyl, alkenyl, alkynyl, trifluoromethyl, or -F; R5 and R6 are each, independently, hydrogen, alkyl, alkenyl, alkynyl, -(CR3R4)fOR10, -CF3, -F, or -CO2R11, or R5 and R6 may be taken together to form X or a cycloalkyl ring that is optionally mono-, di-, or tri-substituted with -(CR3R4)fOR10; R7 is hydrogen, alkyl, alkenyl, alkynyl, -(CR3R4)fOR10, -CF3, -F, or -CO2R11; R8 and R9 are each, independently, hydrogen, alkyl, alkenyl, alkynyl, -(CR3R4)fOR10, -CF3, -F, or -CO2R11, or R8 and R9 may be taken together to form X or a cycloalkyl ring that is optionally mono-, di-, or tri-substituted with -(CR3R4)fOR10; R10 is hydrogen, alkyl, alkenyl, alkynyl, tri-(alkyl)silyl, tri-(alkyl)silylethyl, triphenylmethyl, benzyl, alkoxymethyl, tri-(alkyl)silylethoxymethyl, chloroethyl, or tetrahydropyranyl; R11 is hydrogen, alkyl, alkenyl, alkynyl, or phenylalkyl; X is 5-(2,2-dialkyl)[1,3]dioxanyl, 5-(2,2-dicycloalkyl)[1,3]dioxanyl, 4-(2,2-dialkyl)[1,3]-dioxanyl, 4-(2,2-dicycloalkyl)[1,3]dioxanyl, 4-(2,2-dialkyl)[1,3]dioxalanyl, or 4-(2,2-dicycloalkyl)[1,3]dioxalanyl; b = 0-6; d = 0-6; and f = 0-6 with the proviso that R1 and R2 are both not hydrogen and further provided that either R1 or R2 contains at least one -(CR3R4)fOR10, X, or -(CR3R4)fOR10 substituted cycloalkyl group, or a pharmaceutically acceptable salt thereof which is useful as an immunosuppressive, antiinflammatory, antifungal, antiproliferative, and antitumor agent.
-
Example 11

(2010/01/31)

Chemical Properties

Appearance/Colour :white crystalline powder
Melting Point: 99-101 °C
Boiling Point: 1048.4 °C at 760 mmHg
Flash Point:587.8 °C
Density: 1.2 g/cm³
Solubility:Soluble in chloroform, methanol.
Storage Temp.:-20°C Freezer
Vapor Pressure: 0mmHg at 25°C
Refractive Index: 1.553
PKA: 10.40±0.70(Predicted)
Merck: 14,9142
PSA: 241.96000
LogP: 5.66030

Global suppliers and manufacturers of 162635-04-3total 112 suppliers on LookChem

Company Name
Business Type
Min Order
FOB Price
Main Products
Contact

Dayang Chem (Hangzhou) Co.,Ltd.
Business Type:Lab/Research institutions
Min Order:1 Kilogram
FOB Price:USD $ 3.0-3.0 / Kilogram
Main Products:994
Country:

Simagchem Corporation
Business Type:Manufacturers
Min Order:No Data
FOB Price:No Data
Main Products:110
Country:

Xi'an Xszo Chem Co., Ltd.
Business Type:Manufacturers
Min Order:1 Gram
FOB Price:USD $ 0.1-0.1 / Gram
Main Products:108
Country:

Chemwill Asia Co., Ltd.
Business Type:Manufacturers
Min Order:5 Kiloliter
FOB Price:USD $ 1.2-5.0 / Kiloliter
Main Products:56
Country:

Hubei DiBo chemical co., LTD
Business Type:Other
Min Order:25 Kilogram
FOB Price:USD $ 1.0-2.0 / Kilogram
Main Products:34
Country:

Hebei Nengqian Chemical Import and Export Co., LTD
Business Type:Trading Company
Min Order:1 Kilogram
FOB Price:USD $ 9.0-99.0 / Kilogram
Main Products:165
Country:

Zhuozhou Wenxi import and Export Co., Ltd
Business Type:Trading Company
Min Order:1 Kilogram
FOB Price:USD $ 139.0-210.0 / Kilogram
Main Products:1
Country:

Hebei Sankai Chemical Technology Co., Ltd
Business Type:Trading Company
Min Order:1 Kilogram
FOB Price:USD $ 289.0-499.0 / Kilogram
Main Products:11
Country:

Henan Tianfu Chemical Co., Ltd.
Business Type:Lab/Research institutions
Min Order:1 Kilogram
FOB Price:USD $ 1000.0-1000.0 / Kilogram
Main Products:67
Country:

Shanghai Upbio Tech Co.,Ltd
Business Type:Lab/Research institutions
Min Order:1 Kilogram
FOB Price:USD $ 1.0-1.0 / Kilogram
Main Products:30
Country:

Hubei Langyou International Trading Co., Ltd
Business Type:Other
Min Order:100 Gram
FOB Price:No Data
Main Products:15
Country:

Baoji Guokang Healthchem co.,ltd
Business Type:Trading Company
Min Order:1 Gram
FOB Price:USD $ 260.0-275.0 / Gram
Main Products:41
Country:

Qingdao Beluga Import and Export Co., LTD
Business Type:Lab/Research institutions
Min Order:1 Gram
FOB Price:No Data
Main Products:117
Country:

Shandong Hanjiang Chemical Co., Ltd.
Business Type:Lab/Research institutions
Min Order:1 Kilogram
FOB Price:No Data
Main Products:78
Country:

Henan Wentao Chemical Product Co., Ltd.
Business Type:Lab/Research institutions
Min Order:No Data
FOB Price:No Data
Main Products:44
Country:

Hangzhou JINLAN Pharm-Drugs Technology Co., Ltd
Business Type:Trading Company
Min Order:No Data
FOB Price:No Data
Main Products:86
Country:

Taizhou Crene Biotechnology co.ltd
Business Type:Lab/Research institutions
Min Order:1 Gram
FOB Price:No Data
Main Products:16
Country:

Afine Chemicals Limited
Business Type:Lab/Research institutions
Min Order:1 Gram
FOB Price:No Data
Main Products:95
Country:

Hangzhou Keyingchem Co.,Ltd
Business Type:Lab/Research institutions
Min Order:No Data
FOB Price:No Data
Main Products:102
Country:

Hangzhou Lingrui Chemical Co.,Ltd.
Business Type:Other
Min Order:1 Gram
FOB Price:No Data
Main Products:53
Country:

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 162635-04-3

Article Database

162635-04-3

Articles about 162635-04-3Total 17 be found

More Articles about upstream products of 162635-04-3

More Articles about downstream products of 162635-04-3

Chemical Properties

Appearance/Colour :white crystalline powder

Melting Point: 99-101 °C

Boiling Point: 1048.4 °C at 760 mmHg

Flash Point:587.8 °C

Density: 1.2 g/cm³

Solubility:Soluble in chloroform, methanol.

Storage Temp.:-20°C Freezer

Vapor Pressure: 0mmHg at 25°C

Refractive Index: 1.553

PKA: 10.40±0.70(Predicted)

Merck: 14,9142

PSA: 241.96000

LogP: 5.66030

Global suppliers and manufacturers of 162635-04-3total 112 suppliers on LookChem

Article Database

162635-04-3

Articles about 162635-04-3Total 17 be found

More Articles about upstream products of 162635-04-3

More Articles about downstream products of 162635-04-3

Chemical Properties

Appearance/Colour :white crystalline powder

Melting Point: 99-101 °C

Boiling Point: 1048.4 °C at 760 mmHg

Flash Point:587.8 °C

Density: 1.2 g/cm3

Solubility:Soluble in chloroform, methanol.

Storage Temp.:-20°C Freezer

Vapor Pressure: 0mmHg at 25°C

Refractive Index: 1.553

PKA: 10.40±0.70(Predicted)

Merck: 14,9142

PSA: 241.96000

LogP: 5.66030

Global suppliers and manufacturers of 162635-04-3total 112 suppliers on LookChem

Density: 1.2 g/cm³